Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Treatment of multiple sclerosis (MS) and other demyelinating conditions using lofepramine in combination with L-phenylalanine, tyrosine or tyrptophan and possibly a vitamin B12 compound

US Patent 6569850 · Granted May 27, 2003

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →